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Abstract
The target of rapamycin (Tor) protein plays central roles in cell growth. Rapamycin inhibits cell growth and promotes cell
cycle arrest at G1 (G0). However, little is known about whether Tor is involved in other stages of the cell division cycle. Here
we report that the rapamycin-sensitive Tor complex 1 (TORC1) is involved in G2/M transition in S. cerevisiae. Strains carrying
a temperature-sensitive allele of KOG1 (kog1-105) encoding an essential component of TORC1, as well as yeast cell treated
with rapamycin show mitotic delay with prolonged G2. Overexpression of Cdc5, the yeast polo-like kinase, rescues the
growth defect of kog1-105, and in turn, Cdc5 activity is attenuated in kog1-105 cells. The TORC1-Type2A phosphatase
pathway mediates nucleocytoplasmic transport of Cdc5, which is prerequisite for its proper localization and function. The C-
terminal polo-box domain of Cdc5 has an inhibitory role in nuclear translocation. Taken together, our results indicate a
novel function of Tor in the regulation of cell cycle and proliferation.
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Introduction
Cell growth (increase in cell mass) and proliferation (increase in
cell number) are tightly linked with the cell’s perception of its
nutritional environment. Nutritional information is perceived by
Target of rapamycin (Tor), a phosphatidylinositol kinase-related
Ser/Thr kinase that plays a central role in controlling cell
growth[1]. Tor signaling participates in two complexes; Tor
complex 1 (TORC1) is sensitive to inhibition by rapamycin,
whereas Tor complex 2 (TORC2) is not[2]. Yeast TORC1
consists of either of the two yeast Tor homologs, Tor1 or Tor2
together with co-factors Kog1, Lst8, and Tco89. With the
exception of Tco89, these proteins are essential and widely
conserved in eukaryotes. Rapamycin-sensitive Tor signaling
mediated by TORC1 mainly regulates temporal aspects of cell
growth: protein synthesis, amino acid uptake, autophagy induc-
tion. On the other hand, TORC2, consisting of Tor2, Avo1-3 and
Lst8, regulates spatial aspects of cell growth, e.g. organization of
actin cytoskeleton. TORC1 function is critical for protein synthesis
activities such as translation initiation and ribosome biogenesis[3–
6]. For example, mammalian TORC1 directly phosphorylates
translation initiation factor (eIF) 4E binding protein 1 (4E-BP1) to
abolish its binding and inhibitory activity toward eIF-4E[7]. Yeast
TORC1 stimulates transcription of ribosomal RNA[4], expression
of ribosomal protein genes via protein kinase A (PKA)[5], and
maturation of the 60S ribosome[6]. It is also known that TORC1
is required for G1 progression, as rapamycin causes cell cycle
arrest at early G1 (G0) stage[3]. G0 arrest caused by dysfunction of
Tor is mainly explained by impairment of protein synthesis,
because mutants of genes involved in early G1 progression (e.g.
cdc25, cdc33, and cdc35/cyr1) display a similar phenotype, the
stringent response of macromolecular synthesis[8,9].
Type 2A phosphatase (PP2A) and PP2A-like phosphatase (Sit4)
are identified as major downstream targets of the TORC1
pathway[1,10]. These phosphatases form a complex with Tap42
under the control of TORC1[11]. Though Tap42 used to be
believed to be a negative regulator of phosphatases, several lines of
evidence recently suggest that Tap42-PP2A plays a positive role in
phosphatase activity[10,12]. Phosphotyrosyl phosphatase activator
encoded by RRD1 and RRD2 also binds to Tap42-phosphatase
complex in a Tor-dependent manner, suggesting that TORC1
may regulate substrate specificity of the phosphatases[13].
Involvement of PP2A in TORC1 signaling is also proposed in
mammalian cells[14].
Recently, rapamycin has been studied as an anti-cancer drug,
because it slows the proliferation of many cancer cell lines[1].
Therefore, it is an urgent issue to resolve how rapamycin-sensitive
TORC1 activity influences cell proliferation. However, a detailed
analysis of how Tor regulates the cell cycle through the control of
cell growth has not yet been performed.
PLoS ONE | www.plosone.org 1 May 2008 | Volume 3 | Issue 5 | e2223In this study we generated temperature-sensitive KOG1 mutants
to investigate the relationship of rapamycin-sensitive TOR
signaling pathway to cell cycle progression. Genetic and
biochemical analyses of kog1 mutants led us the unexpected
finding that TORC1 is involved in mitotic entry via regulation of
polo-like kinase, Cdc5. Microscopy revealed that TORC1-PP2A
pathway regulates the nuclear translocation of Cdc5, which is an
indispensable step for its subsequent localization and function.
Using these results, we present a model of how TORC1 facilitates
nuclear transport of Cdc5 to promote mitotic entry.
Results
To closely study the rapamycin-sensitive TORC1 function, we
generated temperature-sensitive mutants of KOG1, an essential
component of TORC1[2,15]. We obtained two temperature-
sensitive alleles, kog1-105 and kog1-117 (Figure 1A). Since these two
mutant alleles showed basically the same phenotype (data not
shown), we chose kog1-105 mutant for further study. At the non-
permissive temperature, kog1-105 cells showed similar phenotypes
to rapamycin-treated cells. For example, MEP2 (ammonium
permease)[16] and CIT2 (peroxisomal citrate synthase) genes[17]
were highly expressed in kog1-105 cell at 37uC (Figure 1B).
Phosphorylation of translation initiation factor eIF-2a[18,19] was
also enhanced (Figure 1C). Consistent with these phenotypes, kog1-
105 exhibited impaired Tor1-Kog1 interaction at the non-
permissive temperature, despite normal levels of Kog1 protein in
the mutant strain (Figure 1D). These results suggest that
incubation of kog1-105 cell at non-permissive temperature causes
dysfunction of TORC1.
When treated with rapamycin, yeast cells terminally arrested at
G1 with 1C DNA content (Figure 1E). It took longer than 6 h to
achieve arrest at G1 by rapamycin, whereas it took only 1–2 h for
reach G1 arrest by a-mating pheromone (data not shown),
suggesting that cell cycle progression is delayed in rapamycin-
treated cell. To our surprise, kog1-105 cells did not arrest at G1 at
37uC; instead they stopped or slowed down cell cycle progression
with 2C DNA content (Figure 1E). Characteristic to G2 phase
these cells had medium to large buds with short spindles and
undivided nuclei (Figure 1F). This unexpected result raised two
questions: why do kog1-105 cells not arrest at G1; and does
rapamycin treatment or nutrient depletion also cause retardation
at G2? To address the first question, yeast cell culture arrested
with nocodazole at metaphase was released into fresh medium.
Cells released into rapamycin-containing medium re-arrested at
G1 as unbudded cells right after they exited mitosis (Figure 2).
However, kog1-105 cells released at non-permissive temperature
progressed through G1, as judged by the emergence of small buds
(Figure 2), indicating that kog1-105 does not arrest at G1 at the
non-permissive temperature. This result also implies that cell cycle
stage delayed by kog1-105 is one that occurs prior to the stage of
arrest caused by nocodazole (metaphase). Autophagy, which is
induced in nutrient-starved cells, was not induced in kog1-105 at
37uC (data not shown), suggesting that incubation of kog1-105 at
the non-permissive temperature may not completely mimic
nutrient starvation, which promotes G1 arrest.
To answer the second question, yeast cells released from a-factor
block in G1 were treated with rapamycin. When released into
rapamycin-containing medium, DNA replication was largely
affected suggesting that most of the cells remained at G1 (data not
shown). We thus added rapamycin 20 min after release. Control cell
culture passed G2 at 40 min and entered mitosis at 60 min, as
judged by FACS analysis, spindle formation, and bud indices
(Figure 3A and B, Figure S1A). On the other hand, rapamycin-
treatedcellsstayed atG2at80 min,andenteredmitosisonlyat100–
120 min. The same experiments were performed using rapamycin-
insensitive mutant, TOR1-1 and kog1-105. Although wild-type cell
exhibited G2 delay (80–100 min) by rapamycin as described, TOR1-
1 showed normal cell cycle progression even in the presence of
rapamycin (Figure S1B). As shown in Figure 1E, kog1-105 also
showed retardation at G2 at the non-permissive temperature (90–
150 min) (Figure S1C). Nutrient depletion also causes mitotic delay.
When G1-arrested cells were released into the nitrogen-depleted
medium, only small portion of cells entered S phase, confirming that
nutrient is indispensable for G1/S transition (data not shown). Thus
synchronously growing cells at S phase (30 min after release into
SCD medium) were shifted into nitrogen-free medium (SD(-N)), and
as a result a significant mitotic delay was observed (100–160 min
time points) (Figure 3C). These results indicate that rapamycin-
sensitive TORC1 function in response to nutrient signal is required
for progression from G2 to mitosis.
Next we screened for multicopy plasmids that rescued the
growth defect of kog1-105 at the non-permissive temperature. As a
result we identified 3 multicopy suppressors, ZDS1, RIM15, and
CDC5 (Figure 4A, data not shown). Of these, only CDC5, the
budding yeast polo-like kinase (Plk)[20], significantly relieved G2-
delay of kog1-105 cell (Figure 4B) when overexpressed (by its own
promoter with a high copy plasmid). We further investigated
whether Cdc5 acts downstream of TORC1.
Cdc5localizes to and functionsat the spindle-polebody (SPB), the
bud neck and the nucleus[21]: SPB-localized Cdc5 plays multiple
roles in mitosis[22,23]; at the bud neck, Cdc5 has two roles—
phosphorylating Swe1 at G2/M[24], and promoting cytokinesis at
mitotic exit[25]; in the nucleus Cdc5 is involved in transcriptional
regulation of CLB2 gene[26]. Cdc5 localization at these sites was
severelyimpairedinkog1-105cells at 37uC(Figure4C).Thiswasalso
disrupted when wild-type cells were treated with rapamycin, though
the effect of rapamycin was canceled in TOR1-1 cells (Figure 4D).
Dysfunction of TORC2 in TOR1tor2-21
ts strain did not exhibit
mislocalization of Cdc5. These results suggest that TORC1 function
(but not TORC2 function) is required for the subcellular localization
of the yeast polo-kinase.
Plks have a conserved nuclear localization signal (NLS) which
mediates their nuclear translocation[27]. We confirmed that
nucleocytoplasmic translocation of Cdc5 is mediated by classical
nuclear import machinery, because nuclear import of Cdc5 was
completely lost in mutants of karyopherin (Kap) complex (srp1 and
kap95 for Kapa and Kapb mutants, respectively)[28], and of the
nuclear pore complex (nup1)[29] (Figure S2A). A mutant version of
Cdc5p with a defective NLS (Cdc5
K171A/R172A/R173A,d e s i g n a t e da s
Cdc5
3A) (FigureS2B)also showedabnormal localization (Figure 5A).
Interestingly, mutation of the Cdc5 NLS (and disruption of nuclear
import machinery) also altered localization of Cdc5 to the SPB and
the bud neck, suggesting that nuclear translocation of Cdc5 is
indispensable for its function, especially prerequisite for its proper
localization to the SPB and the bud neck. This suggestion is
supported bythe fact that expression of Cdc5
3A was unable to rescue
thegrowthdefectofcdc5-1and kog1-105mutants(Figure5A),though
it was normally expressed (Figure S2B).
It is also known that the C-terminal polo-box domain (PBD)
plays important roles in regulation of Plk[20]. We examined the
effect of deletion of the C-terminus on TORC1-mediated
localization of Cdc5. The N-terminal domain of Cdc5 (Cdc5(1-
366)), which includes the whole kinase region and the NLS but
lacks the PBD, localized to the nucleus (Figure 5B). However,
Cdc5(1-366) could not localize to the SPB or the bud neck,
confirming that the PBD is essential for Cdc5 localization to these
sites[30]. Interestingly, Cdc5(1-366) was efficiently transported
Tor Regulates Polo-Kinase
PLoS ONE | www.plosone.org 2 May 2008 | Volume 3 | Issue 5 | e2223Tor Regulates Polo-Kinase
PLoS ONE | www.plosone.org 3 May 2008 | Volume 3 | Issue 5 | e2223into the nucleus in rapamycin-treated cells and in the kog1-105
mutant at 37uC (Figure 5B). The intra-molecular interaction of
mammalian Plk1 between the N-terminal catalytic domain and
the C-terminal PBD is disrupted by T210D substitution
(corresponding to T238 of the yeast Cdc5)[31,32]. We tested the
effect of this mutation on Cdc5 localization in yeast, and found
that GFP-Cdc5
T238D localized normally in kog1-105 cells
(Figure 5B). Cdc5
T238D can function normally, because it
complemented cdc5-1 cells and rescued growth defect of kog1-
105 cells (Figure 5B). These results suggest that in the case of Tor
inactivation the C-terminal domain (presumably the PBD) has an
inhibitory role in nuclear translocation of Cdc5.
Protein kinase activity is indispensable for Cdc5 function. It is
also required for suppression of kog1-105 cells, because overex-
pression of CDC5
N209A, a kinase deficient allele, could not rescue
growth defect of kog1-105 cells (Figure 5B). We closely monitored
Cdc5 activity as cells progressed from G1 to M. In wild-type cells,
Cdc5 became robustly active at the late stages of the cell cycle
Figure 2. kog1-105 cell does not arrested at G1 at non-permissive temperature. Cell cultures (WT (YYK409) and kog1-105 (YYK410)) blocked
in metaphase with 15 mg/ml nocodazole were released into YEPD at 30uC (WT cont.), at 37uC( kog1-105), or 30uC in the presence of 200 ng/ml
rapamycin (WT, rapa.). Budding indices (%) were determined to monitor the cell cycle progression. Cell image (DIC and DAPI staining) of the culture
was shown. Arrow indicates small bud.
doi:10.1371/journal.pone.0002223.g002
Figure 1. Characterization of kog1-105, a temperature-sensitive mutant of KOG1 gene. (A) Wild-type (KOG1, YYK409) and kog1-105
(YYK410) were grown on YEPD at 30uCo r3 7 uC for 2 days. (B) Enhanced expression of starvation-induced gene in kog1-105. Cells grown at 30uC were
incubated at 37uCo r3 0 uC in the presence of 200 ng/ml of rapamycin (Rapa.) for 2 h. Total RNA was extracted and analyzed for expression of MEP2
(top panel) and CIT2 (middle panel) genes by northern blot. RNA amount was monitored by ethidium bromide staining (bottom panel). (C)
Phosphorylation of eIF-2a is enhanced in kog1-105. Cells grown at 30uC were incubated as described in (b). Cell lysate was analyzed by immunoblot
using an anti-phospho eIF-2a antibody (pS51, top panel) and an anti-eIF-2a peptide antibody (bottom panel). (D) Tor1-Kog1 association is unstable in
kog1-105. HA-tagged Tor1 (
HATor1) was immunoprecipitated from wild-type (YAN86) and kog1-105 cells (YAN103) (top panel), and co-precipitated
Flag-tagged Kog1 (
FlagKog1) was detected by immunoblot (middle panel). Noted that protein amount of
FlagKog1 was similar in wild-type and kog1-
105 (bottom panel). (E) Wild-type (KOG1 (YYK409)) and kog1-105 (YYK410) cells grown on YEPD at 30uC were incubated at 37uCo r3 0 uC in the
presence of 200 ng/ml of rapamycin for the indicated times. DNA content was determined by FACS analysis. N.D.; not determined because of loss of
viability. (F) Wild-type (KOG1 (KLY4206)) and kog1-105 (YYK834) cells expressing GFP-tagged tubulin (Tub1-GFP) were treated as in (e) for 4 h. Spindle
formation and DNA (DAPI staining) were observed by immunofluorescent microscope. Percentage of G1 (unbudded cell), S+G2 (budded cell with
short spindle), and M phase (large budded cell with long spindle) cells was also determined.
doi:10.1371/journal.pone.0002223.g001
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PLoS ONE | www.plosone.org 4 May 2008 | Volume 3 | Issue 5 | e2223Figure 3. Rapamycin treatment and nitrogen-depletion induce prolonged G2 phase. (A) Cell culture (KLY4206) arrested at G1 by a-factor
was released into YEPD. Rapamycin (200 ng/ml) was added at 20 min after release. DNA content was measured by FACS analysis. (B) Spindle
formation was monitored by observation of GFP-tagged tubulin (Tub1-GFP). (C) Cell culture (W303-1B) arrested at G1 were released into SCD
medium. Synchronous culture was collected at 30 min and re-released into SCD with/without Rapamycin (200 ng/ml) or nitrogen depleted medium
(SD(-N)). Mating factor was added at 60 min for re-arrest at G1. DNA content was measured by FACS analysis.
doi:10.1371/journal.pone.0002223.g003
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however, Cdc5 only exhibited a basal level of activity, though
Cdc5 in kog1 mutant accumulated as normal as in both wild-type.
Cdc5 plays a critical role in hyper-phosphorylating and degrading
Swe1 prior to G2/M transition[21,22]. Swe1 negatively regulates
mitotic Cdc28 (the yeast cyclin-dependent kinase) by inhibitory
phosphorylation at tyrosine 19[21,22]. During the normal cell
cycle, Swe1 is induced in S phase, becomes progressively
phosphorylated as cells proceed through the cell cycle, and is
largely degraded prior to mitotic entry[21,22]. The level of Swe1
remained stable in a kog1-105 strain at non-permissive temperature
(Figure 6B), and as a result Cdc28 activity was severely attenuated
(Figure 6C). These results suggest that TORC1 regulates Cdc5
activity (and ensuing downregulation of Swe1 and activation of
Cdc28) by controlling its subcellular localization.
In the budding yeast, the organization of the bud neck plays an
important role in G2/M transition. Defects in bud and bud neck
formation or perturbation of actin organization leads to a Swe1-
dependent G2 delay called the morphogenesis checkpoint[34].
Since degradation of Swe1 protein was impaired in kog1-105
mutant, we examined whether morphogenesis checkpoint is
involved in phenotype of kog1 cells. Deletion of SWE1 or
expression of CDC28
Y19F (a mutant of inhibitory phosphorylation
site by Swe1) in a kog1-105 background did not rescue cell growth
at the restrictive temperature (36.5uC) (Figure 6D). At semi-
restrictive temperature (34uC) SWE1 deletion could weakly rescue
kog1 cells (Figure S3C). When monitored Hsl7-GFP as a
morphogenesis-checkpoint-sensitive marker of bud neck fila-
ment[34], we observed normal Hsl7 localization in kog1-105 and
rapamycin-treated cells (Figure S3A). Actin organization is mainly
regulated by rapamycin-insensitive TORC2[1,35], and actin
organization was not affected in kog1-105 cells (Figure S3B).
Localization of Cdc5 was not affected by mutation of CDC42,a
key player in morphogenesis checkpoint[34]. Cdc28 is required for
Cdc5 localization at the bud neck but dispensable for the
localization at the SPB[24]. Induction of Clb2 was moderately
attenuated in kog1 cells (Figure 6C), presumably because nuclear
localized Cdc5 is involved in CLB2 expression[26]. However,
overexpression of CLB2 by GAL1 promoter had an only marginal
effect on rescue of kog1 mutant (Figure 6E, and Figure S3C).
Therefore, we concluded that TORC1-mediated Cdc5 regulation
is distinct from the bud neck pathway.
Evidence has been accumulated that dysfunction of Tor results in
impairment of overall protein synthesis[1]. We asked whether this
decrease of protein synthesis indirectly leads to G2-delay and
abnormal localization of Cdc5. First we examined localization of
Figure 4. TORC1 regulates subcellular localization of Cdc5. (A) Overexpression of CDC5 rescues growth defect of kog1-105 cells. Wild-type
(KOG1 (YYK409)), kog1-105 (YYK410), and kog1-105 strains overexpressing CDC5 (p[CDC5]) were grown on YEPD plates at 30uC or 36.5uC for 2 days. (B)
Overexpression of CDC5 suppresses G2-delay of kog1-105 cells. Wild-type (YYK409), kog1-105 (YYK410), and kog1-105 cells harboring high-copy
plasmid of the indicated genes were arrested at G1 and released into YEPD at 37uC. DNA content was measured by FACS analysis. FACS results of
120 min time point were shown. (C) Cells (WT (YYK409) and kog1-105 (YYK410)) expressing EGFP-Cdc5 grown in SCD at 30uC were incubated at 37uC
or 30uC with 200 ng/ml rapamycin for the indicated times. EGFP-Cdc5 was observed by fluorescent microscope. DNA (nucleus marker) was visualized
by DAPI staining. (D) (Left panels) Wild-type (TOR1 (JK9-3da)) and rapamycin-resistant TOR1-1 (JH11-1c) cells expressing EGFP-Cdc5 grown in SCD at
30uC were treated with 200 ng/ml of rapamycin for 1 h. (Right panels) Wild-type (TOR1TOR2 (JK9-3da)), TOR1tor2-21 (SH121), and tor1Dtor2-21
(SH221) cells expressing EGFP-Cdc5 were incubated at 37uC for 2 h, before observation.
doi:10.1371/journal.pone.0002223.g004
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translation but observed no change in the localization of Cdc5
(Figure S4B). We next examined Cdc5 localization in cyr1, pab1,a n d
cdc33 mutants. CYR1 encodes an adenylate cyclase, playing an
important role in protein synthesis[9,36]. PAB1 and CDC33,
encoding Poly(A)-binding protein and eIF-4E, respectively, both
perform essential roles intranslation initiation[37,38]. Temperature-
sensitive mutants of these essential genes exhibit decreased protein
synthesis, which results in early-G1 arrest[9,37]. In these mutants
incubated at the non-permissive temperature GFP-Cdc5 properly
localized,suchastheSPBandthenucleus(FigureS4B).Itisreported
that the G1 period of exponentially growing cdc33-1 cells is twice as
long as that of wild-type cells, while the duration of S+G2+Mi n
cdc33-1 was only slightly (20%) longer than that of wild-type
cells[38]. When G1-synchronizing cdc33-1 cell culture was released
atnon-permissivetemperature(36uC),budemergencewasabolished
(Figure S4A)[9] due to prolonged G1. On the other hand, when the
cdc33-1 cells were shifted to 36uC after they exited G1 and formed
small buds (105 min), cells completed the entire cell cycle as normal
(270–300 min time points). This suggests that impairment of
translation initiation does not significantly affect G2 progression.
Therefore, we concluded that TORC1 has a distinct role in
regulating subcellular localization of Cdc5 and G2/M transition
irrespective of its effect on protein synthesis.
To determine which factors act downstream of TORC1 to
promote nuclear translocation of Cdc5, we examined mutants of
genes involved in TORC1 pathway (Figure 7A). Protein kinase A
(PKA) is proposed to act downstream of TORC1 for ribosome
biogenesis[5]. However, Cyr1, a key component of PKA pathway
was not required for Cdc5 localization as described above (Figure
S4B). Wefound that Sch9 was not necessary for proper localization of
GFP-Cdc5. Sch9 mediates TORC1-dependent ribosome biogenesis
and translation initiation[39], confirming that impaired protein
synthesis does not affect Cdc5 localization. Rim15, downstream of
PKA and Sch9[39], was also not required for Cdc5 localization.
However, mutation of Tap42 prevented the normal localization of
Cdc5. Tap42 is involved in the regulation of PP2A and PP2A-related
phosphatase Sit4 by TORC1[1,11]. Abnormal localization of GFP-
Cdc5 was observed in a PP2A mutant (pph21Dpph22D for catalytic
subunit), whereas localization appeared normal in a sit4D strain
(Figure 7A). PP2A is known to be required for mitotic entry[40,41],
while Sit4 is involved in G1/S transition[10]. We found that
overexpression of CDC5 rescued the growth defect of pph21D pph22D,
but not of sit4D (Figure 7B). GFP-Cdc5(1-366) displayed normal
nuclear localization in a PP2A mutant (Figure 7A). These results
suggest that the TORC1-PP2A pathway mediates nuclear translo-
cation of Cdc5 via regulation of its intra-molecular interaction.
Discussion
In this study we present evidence that rapamycin-sensitive TOR
(TORC1) pathway plays an important role in G2/M transition.
We also demonstrate that TORC1 contributes to subcellular
localization of Cdc5. It is widely known that TORC1 is required
for G1 progression, and that G1 arrest caused by dysfunction of
TOR (e.g. rapamycin treatment) is mainly due to impaired protein
synthesis. However, in light of our findings with pab1 and cdc33
Figure 5. The C-terminus of Cdc5 has an inhibitory role in its
nuclear translocation. (A) (Top) Cells (W303-1B) expressing EGFP-
Cdc5 (wild-type or NLS mutant (3A)) grown in SCD at 30uC were
observed by fluorescent microscope. (Bottom) Wild-type (CDC5,
KLY1548), cdc5-1 (KLY2156), and cdc5-1 cells harboring the indicated
high-copy EGFP-CDC5 plasmids were spotted onto YEPD plates and
incubated at 30 or 37uC for 2 days. Wild-type (YYK409), kog1-105
(YYK410), and kog1-105 cells harboring the indicated EGFP-CDC5
plasmids were spotted onto YEPD. (B) (Top) Cells (KOG1 and kog1-
105) expressing EGFP-tagged N-terminus of Cdc5 (Cdc5(1-366)) or
T238D mutant (full length) grown in SCD at 30uC were treated with
200 ng/ml rapamycin or incubated at 37uC for 2 h. (Bottom) Experiment
shown in the bottom panel of Figure 5A was carried out using the
indicated high-copy EGFP-CDC5 plasmids.
doi:10.1371/journal.pone.0002223.g005
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regulating protein synthesis is responsible for G2 progression.
Morphogenesis checkpoint is either unlikely to participate in
TORC1-mediated control of Cdc5.
Figure 7. PP2A is involved in localization control of Cdc5. (A) Cells
grown in SCD at 30uC (WT (W303-1B), sch9D (YYK823), rim15D (YYK831),
sit4D (BY9004), pph21Dpph22D (BY9943)) or 24uC( tap42-11,( C Y 5 7 5 5 ) )
expressing EGFP-Cdc5 were shifted to the indicated temperature for 1 h,
and EGFP-Cdc5 was observed by fluorescent microscope. (B) Overexpres-
sion of CDC5 suppresses growth defect of pph21Dpph22D. Wild-type,
pph21Dpph22D,a n dsit4D cells harboring high-copy CDC5 plasmid were
grown on YEPD plates at 30 and 37uC for 2 days. Note that growth defect
of sit4D was exacerbated by CDC5 overexpression.
doi:10.1371/journal.pone.0002223.g007
Figure 6. TORC1 mediates Cdc5 activity. (A) G1-arrested cells (KOG1
(YYK540) and kog1-105 (YYK541)), were released into nocodazole-
containing YEPD medium at 37uC. Samples were harvested at the
indicated times. Cdc5
HA protein was immunoprecipitated, and in vitro
Cdc5 kinase assay was done using casein as a substrate. Note that
induction of Cdc5 was normal in kog1-105 cells (bottom panel). (B) G1-
arrested cells (KOG1 (YYK540) and kog1-105 (YYK541)), were released into
nocodazole-containing YEPD medium at 37uC. Swe1
myc[51] and Cdc5
HA
proteins were detected by immunoblot. (C) G1-arrested cells (KOG1
(YYK861) and kog1-105 (YYK862)), were released as in (a). Cyclin-
dependent kinase assay was performed using histone H1 as a substrate
(top). Amount of Cdc28 and Clb2
HA was also shown (middle and bottom).
(D) Wild-type (YYK409), kog1-105 (YYK410), kog1-105 swe1D (YYK513), and
kog1-105 cells harboring the indicated plasmids (expressed under their
own promoter) were spotted onto YEPD and incubated at the indicated
temperature for 2 days. (E) Wild-type (YYK409), kog1-105 (YYK410) cells
harboring the high copy CDC5 (p[CDC5], expressing under its own
promoter) or CLB2 (p[CLB2], expressing under GAL1 promoter) plasmids
were spotted onto YEPD or YEPgalactose (overexpressing CLB2)a n d
incubated at the indicated temperature for 2 days.
doi:10.1371/journal.pone.0002223.g006
Tor Regulates Polo-Kinase
PLoS ONE | www.plosone.org 8 May 2008 | Volume 3 | Issue 5 | e2223PP2A phosphatase has several essential roles in cell growth and
proliferation. Loss of PP2A function results in cell cycle arrest at
G2[11] and impaired Swe1 degradation[41]. This phenotype
concurs with that of kog1-105 including abnormal localization of
Cdc5, suggesting that Tap42-PP2A branch of TORC1 signaling is
involved in G2/M transition via regulation of Cdc5.
We have further demonstrated that nucleocytoplasmic translo-
cation of Cdc5 is a prerequisite step for its proper function, e.g.
localization and kinase activation. The TORC1-PP2A pathway
promotes Cdc5 translocation across the nuclear membrane. Upon
TORC1 inactivation, nuclear transport of Cdc5 is inhibited,
perhaps because Cdc5 is retained in the cytosol, but this inhibition
is overcome by deletion of the C-terminal PBD domain. These
results are best explained by assuming that dissociation of the N-
terminal catalytic domain (containing the NLS) from the C-
terminal PBD is mediated by TORC1 and promotes NLS
recognition by the Kap complex.
The C-terminal PBD has a critical role in subcellular
localization of Plks. The PBD has a well-studied phosphopep-
tide-binding activity[42], which helps to recruit Plk to the
phosphorylated target proteins at specific cellular locations[23].
Phosphopeptide binding by the PBD disrupts certain intramolec-
ular interactions and lets the kinase domain to be activated[20]. In
the resting state, phosphopeptide binding is inhibited by
interaction with the kinase domain and the kinase activity is
repressed by the association of the PBD[42]. The intra-molecular
interaction between the kinase domain and the PBD might thus
inhibit nuclear import, recruitment to the target sites, and kinase
activity. Our results indicate that nuclear translocation occurs
prior to the targeting and the activation, because proper
localization and kinase activation of Cdc5 are compromised when
its nuclear translocation is prohibited.
Beyond its critical role in G2/M transition, Plk has subsequent
essential roles in mitosis[20,22]. In yeast, Cdc5 is essential for
mitotic exit[22]. It is postulated that SPB movement from mother
cell to daughter during anaphase sends a signal to Cdc5 at mitotic
exit[22]. However, we did not detect any defect at mitotic exit in
kog1-105 or rapamycin-treated cells when they were released from
nocodazole arrest (see Figure 2). Therefore, regulation of Cdc5 by
TORC1 is restricted at G2/M transition, and it is unlikely that
TORC1 regulates Cdc5 at mitosis.
During the course of our study, a report was published
suggesting that Tor regulates mitotic entry in the fission yeast,
Schizosaccharomyces pombe[43]. However, their conclusion is com-
pletely opposite to ours; rapamycin treatment stimulates mitotic
entry in the fission yeast. We assume that this discrepancy comes
from the difference of rapamycin-sensitivity of these two species.
The budding yeast used in this study is highly sensitive to
rapamycin, whereas cell proliferation of the fission yeast is not
inhibited by rapamycin[44,45]. Presumably rapamycin-FKBP12
complex can bind to and inhibit Tor in the fission yeast cells,
because components of Tor complex and FKBP12 are widely
conserved among eukaryotes including the two yeasts[46]. We
speculate that some downstream pathway(s) of Tor signaling is
abrogated in the rapamycin-resistant yeast. Description of
rapamycin-resistance in some cancer cell line (e.g. rhabdomyo-
sarcoma Rh30) is reported[47,48], thus identification of discon-
nected circuit in TORC1 signaling which confers rapamycin-
insensitivity should be quite informative for application of
rapamycin as an anti-cancer drug. Judging from the phosphory-
lation of eIF-2a, Gcn2 kinase is activated by rapamycin in the
budding yeast[18,19] (Figure 1C), though it is not activated in the
fission yeast[43] (Nakashima et al. unpublished result). As deletion
of GCN2 or mutation of SUI2 (encoding eIF2a) confers the
budding yeast cell on rapamycin-resistance[18], Gcn2 might be
a good candidate for a key factor to determine rapamycin-
sensitivity.
Nutrients have two important roles in cell growth. One is to
provide material for macromolecule synthesis, and the other is as a
signal molecule of Tor pathway. Tor monitors nutrient levels and
integrates this information to control cell growth. The fundamental
relationship between cell growth and cell cycle was reported by an
early landmark study using budding yeast[8]. This study demon-
strated that cell growth occurs throughout whole cell cycle, because
cell growth is not perturbed in cdc mutants (except cdc25 and cdc33)
arrested at various stage in cell cycle. Taking their conclusion into
consideration, we assume that TOR signaling remains active during
whole cell cycle, acting not only to upregulate macromolecular
synthesis, but also to transmit nutrient signals to other downstream
factors that promote cell cycle progression. Under nutrient-limiting
conditions, the best stage to arrest cell growth is at G1. However,
after cells exit G1, it is better to slow down cell cycle progression at
G2 and to wait for nutrient levels to recover, because mitosis is the
most elaborate and energy-consuming event in cell cycle. Our
findings suggest that Tor could play another pivotal role in cell cycle
monitoring, determining whether cell growth and nutrient condi-
tions are sufficient to permit mitosis.
Materials and Methods
Strains, Plasmids, Media and Genetic methods
Yeast strains used in this study are listed in Supporting
Information, Table S1. Standard techniques (growth media, cell
growth condition, transformation etc.) were used for yeast manipu-
lation[49]. Cloning of 5.4-kb DNA fragment containing KOG1 gene
was carried out by PCR. N-terminal Flag-tagging of KOG1 and HA-
tagging of TOR1[2] were done using Quikchange (Stratagene).
Moleucular Biological Methods
Total RNA was isolated using TRIZOL Reagent (Invitrogen),
and northern blot was performed using Random Primer DNA
Labeling Kit (TaKaRa) and analyzed by BAS2500 (Fuji Film).
Total cell extract was prepared as described below. For
immunoblot, anti-HA (16B12, BAbCO), anti-Flag (M2, Sigma),
anti-myc (9E10), anti-phospho-eIF2a (pS51, Stressgen), anti-eIF2a
(Stressgen), and anti-Cdc2 (PSTAIRE, Santa Cruz) were used.
Screening of the kog1
ts Alleles and the Multicopy
Suppressors
Temperature sensitive KOG1 mutant was conducted by
mutagenic PCR. The mutagenized gene was co-transformed into
YYK400 cell (kog1D::LEU2 pRS316[KOG1
WT]) with a gapped
pRS314[KOG1] plasmid. The transformants were replicated on 5-
fluoro-orotic acid medium to isolate uracil auxotrophs. One
hundred colonies were picked and patched onto SCD-Trp plates,
and they were screened for temperature sensitivity at 33, 35 and
37uC. Plasmids recovered from 3 colonies that passed the initial
screening were used for the second screening. As a result, we
obtained 2 kog1 temperature-sensitive allele, kog1-105 and kog1-
117. We subcloned KOG1
WT and kog1-105 into pRS313 plasmid,
transformed them into YYK400, and isolated uracil auxotrophs to
generate YYK409 (WT) and YYK410 (kog1-105) cells.
Multicopy suppressor screening of kog1-105 strain was done
from 5610
8 library transformants as described[35]. Screening was
carried out at 36.5uC. As the result of the third screening we
obtained 17 multicopy suppressor candidates. Among them, we
succeeded in identifying 3 genes, CDC5, ZDS1, and RIM15.
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(FACS) Analysis
Cell synchronization in G1 was obtained by treatment of
exponentially growing Mata cells with 5 mM a-factor mating
pheromone for 2 h. Yeast cells were synchronized in M by treating
growing cells with 15 mg/ml nocodazole for 2 h at 30uC. The G1 or
M-arrested cells were washed with distilled water three times,
released into fresh YEPD or SCD medium, and cells were collected
at the indicated time. For FACS analysis, cells were fixed by ethanol
for1 h(orlonger),washed by50 mMsodiumcitrate in50 mMTris-
HCl pH 7.5, and suspended in50 mMTris-HCl pH 7.5. Cells were
treated with 1 mg/ml of RNaseA at 37uC for 1h, then treated with
40 mg/ml of proteinase K at 55uC for 1 h, and washed and
suspendedinPBSbuffer.Theresultingcellswerestainedby100 mg/
ml propidium iodide at room temperature for 1 h. The DNA
content of cells was measured on Beckman-Coulter EPICS XL flow
cytometer. Nocodazole (Sigma) and rapamycin (Sigma) were used at
the final concentration of 15 mg/ml and 200 ng/ml, respectively.
Immunoprecipitation and Protein Kinase Assay
YEPD-grown cells were collected, washed once with distilled
water, and suspended in ice-cold CDC5 lysis buffer (16 PBS,
pH 7.4, 1 mM EDTA, 1 mM EGTA, 1 mM Na3VO4,1 5m Mp-
nitrophenylphosphate (pNPP), 1 mM dithiothreitol (DTT), 20 mg/
ml leupeptin, 20 mg/ml benzamidine, 10 mg/ml pepstatin A,
40 mg/ml aprotinin, 1 mM PMSF). Cells were broken by vortexing
with glass beads for 10 min at 4uC. The beads and cell debris were
removed by centrifugation for 5 min at 15,0006ga t4 uC, and the
supernatant was further clarified by additional 20-min centrifuga-
tion. Immunoprecipitation of Cdc5
HA was carried out as de-
scribed[35] using anti-HA ascites. Immunoprecipitated protein was
suspended with 27 ml of CDC5 kinase assay buffer (50 mM Mops-
KOH pH 7.5, 10 mM MgCl2, 2 mM EGTA, 0.4 mM Na3VO4,
1m MD T T ,1 5m MpNPP) containing 6 mgo fc a s e i n( S i g m a ) .T h i s
mixture was preincubated for 3 min at 30uC, the reaction was
initiated by adding 3 ml of 0.5 mM [c-
32P]ATP (Amer-
sham)(10 mCi/sample). After incubation for 30 min at 30uC, the
reaction was terminated by adding 30 mlo f2 6SDS-PAGE sample
buffer and incubated for 5 min at 65uC. Samples were analyzed by
SDS-PAGE and autoradiography as described[35]. In vitro protein
kinase assay of Cdc28 was performed as described[50].
Observation of EGFP-tagged Protein
EGFP-tagged Cdc5 protein was expressed by high copy plasmid
(pRS424, 425, or 426[EGFP-CDC5]) under control of authentic
promoter[23]. EGFP was chromosomally tagged into TUB1 as
described[30]. Cells were grown to early logarithmic phase in
synthetic medium (SCD). Cells images were acquired using GFP
filter[35]. Actin staining using 0.1 U/ml of rhodamine-phalloidin
(Sigma) as described[35]. Nuclear DNA was visualized by 10 mg/
ml of DAPI.
Supporting Information
Figure S1 Rapamycin-sensitive TORC1 pathway is involved in
mitotic entry. (A) Percentage of G1 (unbudded cell), S+G2
(budded cell with short spindle), and M phase (large budded cell
with long spindle) of experiment shown in Figure 3A and B was
shown. (B) Wild-type (WT (JK9-3da)) and rapamycin-resistant
TOR1-1 mutant (JH11-1c) arrested at G1 were released into
YEPD. Rapamycin (200 ng/ml) was added at 20 min after release
and mating factor was added at 60 min for re-arrest at G1. DNA
content was measured by FACS analysis. (C) Wild-type (YYK409)
and kog1-105 (YYK410) cells arrested at G1 were released into
YEPD at 37uC. Mating factor was added at 60 min for re-arrest at
G1. DNA content was measured by FACS analysis.
Found at: doi:10.1371/journal.pone.0002223.s001 (10.00MBTIF)
Figure S2 Karyopherin-mediated nuclear transport of Cdc5 is
essential to Cdc5 function. (A) Karyopherin a and b mediate
nuclear localization of Cdc5. Cells expressing GFP-Cdc5 (by
pRS426[EGFP-CDC5]) grown in SCD at 24uC( SRP1 (W303-1B),
srp1-31 (NOY612), and kap94-14)o r3 0 uC( NUP1 (BY4741),
nup1D36 (MRY120)) were observed by fluorescent microscope. As
for kap95-14 mutant, cells grown at 24uC were incubated at 37uC
for 1 h. (B) (Left) A conserved NLS domain in Cdc5. We searched
classical NLS motifs using PSORTII program and found two
putative NLS sequences,
58KKKR and
171KRRK. The latter site,
well conserved among polo-like kinases, was mutated to generate
cdc5K171A/R172A/R173A (cdc5
3A). Mutation at the former site
did not have any effect on GFP-Cdc5 localization (data not
shown). (Right) Cdc5
3A protein is expressed at similar level with
wild-type Cdc5. HA-tagged Cdc5 protein was detected by
immunoblot.
Found at: doi:10.1371/journal.pone.0002223.s002 (8.69 MB TIF)
Figure S3 Bud neck organization is not affected by loss of
TORC1 function (A) Cells (WT (YYK409) and kog1-105
(YYK410)) expressing GFP-Hsl7 were incubated at 37uC( kog1-
105) or with 200 ng/ml rapamycin for 4 h. GFP-Hsl7 localizing at
the bud neck was observed by fluorescent microscope. (B) (Top)
Cells (WT (YYK409) and kog1-105 (YYK410)) incubated at 37uC
were fixed and actin was stained with rhodamine-phalloidin.
(Bottom) EGFP-Cdc5 of cdc42-1 (YKT366) incubated at 37uC for
2 h was observed by fluorescent microscope. (C) (Top) Wild-type
(YYK409), kog1-105 (YYK410), kog1-105 swe1D (YYK513), and
kog1-105 cells harboring the indicated plasmids (expressed by their
own promoter) were spotted onto YEPD and incubated at the
indicated temperature for 2 days. (Bottom) Wild-type (YYK409),
kog1-105 (YYK410) cells harboring the high copy CDC5
(p[CDC5], expressing Cdc5 by its own promoter) or overexpress-
ing CLB2 (p[CLB2], expressing under GAL1 promoter) plasmids
were spotted onto YEPD or YEPgalactose (overexpressing Clb2)
and incubated at the indicated temperature for 2 days.
Found at: doi:10.1371/journal.pone.0002223.s003 (10.07MBTIF)
Figure S4 Decrease of translation rate is not the primary reason
of prolonged G2 or abnormal localization of Cdc5 (A) Temper-
ature-sensitive cdc33-1 mutant (E17) was arrested at G1 by a-factor
at 24uC, and released into YEPD medium. Cell culture was
incubated at 24uC (left), 36uC (middle), or growth temperature was
shifted from 24uCt o3 6 uC at 105 min (when nearly 50% of the
cells exited G1 phase). Budding indices (%) were determined to
monitor the cell cycle progression. (B) Exponentially growing cells
(WT (YYK409), cyr1-200 (HM57-2C), pab1-F364L (YAS120), and
cdc33-1 (CB101)) expressing EGFP-Cdc5 were incubated as
indicated, and EGFP-Cdc5 was observed by fluorescent micro-
scope. CHX, treatment with 10 mg/ml of cycloheximide. As for
cyr1, pab1 and cdc33-1 mutants, about 10% population of the
culture at the non-permissive temperature was still budded cells
(data not shown).
Found at: doi:10.1371/journal.pone.0002223.s004 (9.39 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0002223.s005 (0.06 MB
DOC)
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